Report overview
The global Omega-3 Ingredients for Pharmaceuticals market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Docosahexaenoic Acid Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Omega-3 Ingredients for Pharmaceuticals include Avestia Pharma, Novasep, AbbVie Inc, KD Pharma Group, BASF SE, Corbion, DSM, AstraZeneca and GSK plc, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Omega 3 ingredients are naturally occurring polyunsaturated fatty acids and nutrients that are essential for optimal human health. There are three kinds of omega-3 ingredients, namely, eicosapentaenoic acid (EPA), alpha-linoleic acid (ALA), and docosahexaenoic acid (DHA). EPA and DHA are mostly extracted from fish and ALA is mainly extracted from plants sources such as seeds and nuts.
This report aims to provide a comprehensive presentation of the global market for Omega-3 Ingredients for Pharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Omega-3 Ingredients for Pharmaceuticals. This report contains market size and forecasts of Omega-3 Ingredients for Pharmaceuticals in global, including the following market information:
Global Omega-3 Ingredients for Pharmaceuticals Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Omega-3 Ingredients for Pharmaceuticals Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five Omega-3 Ingredients for Pharmaceuticals companies in 2023 (%)
We surveyed the Omega-3 Ingredients for Pharmaceuticals manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Omega-3 Ingredients for Pharmaceuticals Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Omega-3 Ingredients for Pharmaceuticals Market Segment Percentages, by Type, 2023 (%)
Docosahexaenoic Acid
Eicosapentaenoic Acid
Alpha-Linolenic Acid
Global Omega-3 Ingredients for Pharmaceuticals Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Omega-3 Ingredients for Pharmaceuticals Market Segment Percentages, by Application, 2023 (%)
Cardiovascular Diseases
Autoimmune Diseases
Bone & Joint Disorders
Neurological Disorders
Other
Global Omega-3 Ingredients for Pharmaceuticals Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Omega-3 Ingredients for Pharmaceuticals Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Omega-3 Ingredients for Pharmaceuticals revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Omega-3 Ingredients for Pharmaceuticals revenues share in global market, 2023 (%)
Key companies Omega-3 Ingredients for Pharmaceuticals sales in global market, 2019-2024 (Estimated), (K Units)
Key companies Omega-3 Ingredients for Pharmaceuticals sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Avestia Pharma
Novasep
AbbVie Inc
KD Pharma Group
BASF SE
Corbion
DSM
AstraZeneca
GSK plc
Fresenius Kabi AG
Croda International Plc
AMARIN CORPORATION
ANI Pharmaceuticals, Inc
Epax
Strides Pharma Science Limited
Pharma Marine AS
KinOmega Biopharm Inc
Camber Pharmaceuticals, Inc
Outline of Major Chapters:
Chapter 1: Introduces the definition of Omega-3 Ingredients for Pharmaceuticals, market overview.
Chapter 2: Global Omega-3 Ingredients for Pharmaceuticals market size in revenue and volume.
Chapter 3: Detailed analysis of Omega-3 Ingredients for Pharmaceuticals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Omega-3 Ingredients for Pharmaceuticals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Omega-3 Ingredients for Pharmaceuticals capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
